Kaiser Permanente Washinton Health Research Institute
Seattle, Washington, 98101, United States
NCT Number: NCT01052922
Ancillary Aim #1 We will evaluate intervention effects by comparing binary outcomes for screening (yes/no) in the primary SOS study. In this aim, we propose to calculate actual screening rates by use of time-to-event analyses (also known as survival analysis). The outcome variable of interest is the first time since randomization to have CRCS, either based on FOBT, FS, or CS. Knowing screening rates will not only enable us to make comparisons between groups, but also over time.
Ancillary Aims #2 and #3 We will recruit additional participants for two ancillary study aims. First, we will enroll patients age 50-74 years using the same criteria as for the primary SOS study, which includes neither history of colorectal cancer nor evidence of life-limiting disease. Participants who return the questionnaire, consent and considered eligible will be randomized to receive one of three different at-home fecal test kits. The kits will be returned to the GH centralized laboratory, and participants will be informed about lab results using standard GH pathways. Participants who have a test-positive will receive a series of two follow-up surveys (first at 1-2 weeks post result and second at 4-months post result). A comparison group of test-negative results will be matched based on selected criteria, and this group will also receive the follow-up surveys. Participants at both time intervals who do not return the survey via mail will be called and if available, administered the questionnaire via phone.
Looking for future studies?
Notify Me50 year–74 year
All sexes
Interventional
Not applicable
Seattle, Washington, 98101, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be mailed to a 3 sample g-SENSA FOBT kit to complete at home and mail back to the lab for screening.
Participants will be mailed to a 2 sample InSure FOBT kit to complete at home and mail back to the lab for screening.
Participants will be mailed to a 1 sample OC-MICRON FOBT kit to complete at home and mail back to the lab for screening.
Time frame: 1-2 months
Kaiser Permanente
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06666556
Colonic Diseases, Colorectal Cancer Screening
Guadalajara, Jalisco, Mexico
View Trial DetailsNCT06982053
Colonic Diseases, Colorectal Cancer Control and Prevention
Wuhan, China
View Trial DetailsNCT04683744
COVID-19, Colonic Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT03959696
Colonic Diseases, Colorectal Cancer Screening
Portland, Maine, United States
View Trial Details